Clinical trial Recruiting at 1 site Observational Ages 18 to 80

OSA Screening in Diverse Populations

Official title: Screening for Obstructive Sleep Apnea-hypopnea Syndrome - for Community Populations, Patients With Specific Diseases and Special Populations

Run by Guangzhou Institute of Respiratory Disease · NCT07736872 · Data updated 2026-11-12

This study tests how common obstructive sleep apnea is across community members and people with certain diseases in China, using screening questionnaires and polysomnography or portable sleep monitors.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment100000 (estimated)
SponsorGuangzhou Institute of Respiratory Disease
Academic / other
Locations2 sites (Guangzhou, Guangdong and 1 other locations)
StatusRecruiting
StartedSeptember 1, 2024
Main results expectedAugust 1, 2027
Study endsAugust 1, 2027
Registry record updatedJuly 30, 2026
Trial IDNCT07736872 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults in China from community settings, or with hypertension, COPD, diabetes, cardiovascular disease, or other OSA-related conditions, who can consent and complete questionnaires.

Probably not a fit

Individuals unlikely to have OSA or who do not complete the questionnaires or tests may receive no direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study in China aims to determine the prevalence and clinical features of obstructive sleep apnea-hypopnea syndrome in community residents, patients with specific diseases, and special populations. It uses random sampling to select participants and administers standardized screening questionnaires, with a subset undergoing PSG or portable sleep monitoring to confirm results. The study applies cluster sampling for communities and computer-based randomization to classify high- and low-risk individuals for further testing. It seeks to evaluate the value of different screening tools across diverse populations. Recruiting is ongoing with 2,185 participants enrolled to date across multiple centers.

Why it matters

Potential benefit: If successful, the study could improve understanding of who is at risk for OSA in diverse groups and help tailor screening approaches.

How similar studies have gone: Previous studies using diverse populations and questionnaire-based screening coupled with objective testing have shown meaningful insights into OSA prevalence and screening performance.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Sign the informed consent form before participating in the study
* Complete independent behaviour and cognitive abilities
* Ability to answer the questionnaire completely and accurately

Exclusion Criteria:

* Incomplete answers to the scale
* Patients with severe diseases and acute infections or those requiring long-term home oxygen therapy
* Patients with severe mental and psychological disorders
* Patients with severe organ failure
* patients with a total sleep time \<240 min by PSG or PM

Where it's running

  • The First Affiliated Hospital of Guangzhou Medical University
    Guangzhou, Guangdong, China
    Recruiting
  • Anshun People's Hospital
    Anshun, Guizhou, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.